Environmentally responsive hydrogel promotes vascular normalization to enhance STING anti-tumor immunity

Area of Science:

• Immunology
• Biomedical Engineering
• Oncology

Background:

• Tumor microenvironments create immunosuppression, hindering anti-tumor therapies.
• Abnormal tumor vasculature exacerbates immune cell dysfunction and tumor progression.
• Previous studies showed individual efficacy of c-di-AMP and RRx-001 against tumors.

Purpose of the Study:

• To investigate the synergistic anti-tumor effects of combining c-di-AMP and RRx-001.
• To develop a novel drug delivery system using hydrogel scaffolds for targeted therapy.
• To evaluate the combination's impact on tumor immunosuppression and vascular normalization.

Main Methods:

• Loading c-di-AMP and RRx-001 onto PVA-TSPBA hydrogel scaffolds for in situ tumor injection.
• Assessing the activation of the STING pathway by c-di-AMP.
• Evaluating the nitric oxide release and apoptosis induction by RRx-001.
• Analyzing the combined effects on immune cell infiltration, vascular normalization, and tumor immunosuppression.

Main Results:

• c-di-AMP activated the STING pathway, boosting immune cell infiltration and reversing immunosuppression.
• RRx-001 induced tumor cell apoptosis via nitric oxide release.
• The combination therapy demonstrated superior vascular normalization and immunosuppression reversal compared to monotherapy.
• The hydrogel scaffold facilitated targeted drug release within the tumor microenvironment.

Conclusions:

• The combination of c-di-AMP and RRx-001 shows significant synergistic anti-tumor immunotherapy potential.
• Tumor environmentally responsive hydrogel scaffolds offer a viable strategy for combined anti-tumor therapy.
• This approach presents a novel design for enhancing anti-tumor treatment efficacy.